Last reviewed · How we verify

NCT05403931: LLLT OA

The Effectiveness of Low Level Laser Therapy on Particular Joint Points and Acupuncture Points on Knee Joints in Grade III Knee Osteoarthritis

Status unknown NA Last updated 17 May 2023
What this trial tests

NA trial testing Low level laser therapy in Knee Osteoarthritis in 50 participants. Status unknown.

Timeline
30 April 2022
Primary endpoint
30 July 2023
30 September 2023

Quick facts

Lead sponsorUniversiti Teknologi Malaysia
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment50
Start date30 April 2022
Primary completion30 July 2023
Estimated completion30 September 2023
Sites1 location across Pakistan

Drugs / interventions tested

Conditions studied

Sponsor

Universiti Teknologi Malaysia

Who can join

35 and older, any sex, with Knee Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

LLLT is in use to treat different musculoskeletal condition. Osteoarthritis is one of the conditions needing LLLT for therapeutic effects. LLLT has been used in different previous studies using different points on joint and also on acupuncture points. This study is going to compare the effectiveness of LLLT on both points. Omega xp device is going to be used in this study.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Low level laser therapy

Trials testing the same drug.

Other recruiting trials for Knee Osteoarthritis

Currently open trials in the same condition.

Other Universiti Teknologi Malaysia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05403931.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing